• Brain research · Mar 2020

    Pain-related changes in cutaneous innervation of patients suffering from bortezomib-induced, diabetic or chronic idiopathic axonal polyneuropathy.

    • Malik Bechakra, Mariska D Nieuwenhoff, Rosmalen Joost van JV Dept. of Biostatistics, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands., Groeneveld Geert Jan GJ Centre for Human Drug Research, Zernikedreef 8, 2333CL Leiden, the Netherlands., J P M Huygen Frank F Dept. of Anesthesiology, Erasmus MC, Dr. Molewaterplein 40, 3015GD Rotterdam, the Netherlands., Zeeuw Chris I de CI Dept. of Neuroscience, Erasmus MC, Dr. Molewaterplein 50, 3015GE Rotterdam, the Netherlands; Netherlands Institute for Neuroscience, Royal Academy of , Doorn Pieter A van PAV Dept. of Neurology, Erasmus MC, Dr. Molewaterplein 40, 3015GD Rotterdam, the Netherlands., and Jongen Joost L M JLM Dept. of Neurology, Erasmus MC, Dr. Molewaterplein 40, 3015GD Rotterdam, the Netherlands. Electronic address: j.jongen@erasmusmc.nl..
    • Dept. of Neurology, Erasmus MC, Dr. Molewaterplein 40, 3015GD Rotterdam, the Netherlands; Dept. of Neuroscience, Erasmus MC, Dr. Molewaterplein 50, 3015GE Rotterdam, the Netherlands.
    • Brain Res. 2020 Mar 1; 1730: 146621.

    AbstractConsistent associations between the severity of neuropathic pain and cutaneous innervation have not been described. We collected demographic and clinical data, McGill Pain Questionnaires (MPQ) and skin biopsies processed for PGP9.5 and CGRP immunohistochemistry from patients with bortezomib-induced peripheral neuropathy (BiPN; n = 22), painful diabetic neuropathy (PDN; n = 16), chronic idiopathic axonal polyneuropathy (CIAP; n = 16) and 17 age-matched healthy volunteers. Duration of neuropathic symptoms was significantly shorter in patients with BiPN in comparison with PDN and CIAP patients. BiPN was characterized by a significant increase in epidermal axonal swellings and upper dermis nerve fiber densities (UDNFD) and a decrease in subepidermal nerve fiber densities (SENFD) of PGP9.5-positive fibers and of PGP9.5 containing structures that did not show CGRP labeling, presumably non-peptidergic fibers. In PDN and CIAP patients, intraepidermal nerve fiber densities (IENFD) and SENFD of PGP9.5-positive and of non-peptidergic fibers were decreased in comparison with healthy volunteers. Significant unadjusted associations between IENFD and SENFD of CGRP-positive, i.e. peptidergic, fibers and the MPQ sensory-discriminative, as well as between UDNFD of PGP9.5-positive fibers and the MPQ evaluative/affective component of neuropathic pain, were found in BiPN and CIAP patients. No significant associations were found in PDN patients. Cutaneous innervation changes in BiPN confirm characteristic features of early, whereas those in CIAP and PDN are in line with late forms of neuropathic pathology. Our results allude to a distinct role for non-peptidergic nociceptors in BiPN and CIAP patients. The lack of significant associations in PDN may be caused by mixed ischemic and purely neuropathic pain pathology.Copyright © 2020 Elsevier B.V. All rights reserved.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.